Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201010741 Principal Investigator: Linette, Gerald
Title: Phase I/II study to assess the safety and activity of enhanced TCR transduced autologous T cells against cancer-testis antigens in metastatic melanoma
Phase: I/II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this clinical trial is to assess the effects (both good and bad) of chemotherapy and treatment with modified T cells on cancer and general health.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)